Edward A Levine is Professor of Surgery and chief of the Surgical Oncology Service at the Wake Forest Comprehensive Cancer Center. He is one of five specialists of the Surgical Oncology Service at WFU. He joined the Wake Forest University faculty in August 1998 and was promoted to Professor in 2002.
Dr. Levine is the chief of the Wake Forest University program of Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy (HIPEC) for Peritoneal Carcinomatosis; this is the second largest such program in the western hemisphere.
Dr. Levine's clinical interests are related to general surgical oncology, including gastrointestinal malignancies. He is director of the Surgical Oncology Clinics in the new Cancer Center Building, the multimodality breast clinic and the surgical oncology Conference (“Tumor Board”) for the Comprehensive Cancer Center.
Dr. Levine has published over 150 scientific articles and book chapters. He is the principal investigator for approximately 25 current clinical/translational protocols and is committed to clinical/translational research. These involve the National Surgical Breast and Bowel Project (NSABP) and the American College of Surgeons Oncology Group (ACOSOG) for which he is the institutional principal investigator.
He is also the recipient of grants from the National Cancer Institute, Industry, and Cancer Center funding translational research involving the genomic analysis of solid tumors
In addition to his administrative and teaching duties involving the Wake Forest Comprehensive Cancer Center and the Surgical Oncology Service, Dr. Levine also serves on the Breast and Colorectal committees of the NSABP and is the Chair of the Cancer Committee for the Wake Forest University/North Carolina Baptist hospital.
Read Dr. Levine’s profile, as well as the profiles of his colleagues, Dr. Perry Shen and Dr. John Stewart, on the HIPEC Treatment Centers page at www.pmppals.org